Resistance Trends and Epidemiology of Citrobacter-Enterobacter-Serratia in Urinary Tract Infections of Inpatients and Outpatients (RECESUTI): A 10-Year Survey.

Conclusions: Resistance developments of CES bacteria, coupled with their intrinsic non-susceptibility to several antibiotics, severely limits the number of therapeutic alternatives, especially for outpatients. PMID: 31216725 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31216725?dopt=Abstract

Source: Medicina (Kaunas) - June 17, 2019 Category: Universities & Medical Training Authors: Gajdács M, Urbán E Tags: Medicina (Kaunas) Source Type: research

More News: Epidemiology | Study | Universities & Medical Training | Urinary Tract Infections